Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, ...

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

AC Immune said its immunotherapy showed the potential to slow the progression of Parkinson’s disease, based on preliminary ...

Health system lawyers are silent on why hospitals don't keep AI scribe transcripts for quality and accuracy research.

In the past twenty years, the number of hospitals that are capable of treating kids and adolescents has dropped significantly ...

At a health care AI summit in Washington D.C. yesterday, heavy hitters weighed in on the prospects for interoperability — the ...

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

A raging bull market for biotech stocks and a good story have transformed an ineffective weight loss drug into a Wall Street ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again ...